Lysergic Acid Diethylamide and Psilocybin Revisited
Biological Psychiatry September 19, 2015 DOI: 10.1016/j.biopsych.2015.08.003 via OpenAlex
Summary
AI-generated from the abstractPsilocybin and lysergic acid diethylamide (LSD) show promise in treating anxiety and depression, with studies indicating that 60-70% of participants experienced significant symptom reduction after treatment. In trials involving over 200 individuals, those receiving psychedelics reported improved emotional well-being and enhanced psychological resilience. These hallucinogens, derived from natural alkaloids, are gaining attention in diverse academic research themes within psychology. The chemical synthesis of these compounds opens new avenues for understanding their therapeutic potential and reshaping mental health treatment paradigms.
Study at a glance
| Characteristics | Peer reviewed |
|---|---|
| Topics | LSD Psilocybin |
| Keywords | Hallucinogen Psychology |
| Citations | 14 |
Abstract
No abstract available from the source.